Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database

被引:97
作者
Kumlien, Eva [1 ]
Lundberg, Per Olov [1 ]
机构
[1] Uppsala Univ, Dept Neurosci, Uppsala, Sweden
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2010年 / 19卷 / 02期
关键词
ATC-classification; Adverse drug reactions; Convulsions; Nervous system; Seizures; PSYCHOTROPIC-DRUGS; EPILEPSY; ANTIDEPRESSANTS; PROCONVULSANT; DYSFUNCTION; DOPAMINE; SYSTEM; ADULTS;
D O I
10.1016/j.seizure.2009.11.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: To explore the association between the use of neuroactive drugs and reports of epileptic seizures. Material: Using the WHO adverse drug reactions (ADR) database, VigiBase, we surveyed reports of suspected seizures from 1968 until February 2006. Case reports of ADRs, that were classified as convulsions were collected and compared to the total number of ADRs reported. Results: The total number of ADRs was 7,375,325. The number of convulsive events was 71,471. The ratio of convulsive ADRs to the total number of ADRs reported for each drug was evaluated and expressed as a percentage. The 10 drugs roost frequently associated With Convulsive ADRs were maprotilene (14.42%), escitaloprame (9.78%), buproprione (9.49%), clozapine (9.0%), chlorprothiexene (8.89%), amoxapine (8.74%), donepezil (8.40%), rivastigmine (6.41%), quetiapine (5.90%) and trimipramine (5.69%). Conclusions: Based oil the reports in VigiBase, ADR reports relating to antidepressants, antipsychotic and cholinomimetic drugs included seizures more often than other neuroactive drugs. (C) 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 28 条
[1]  
Alldredge BK, 1999, NEUROLOGY, V53, pS68
[2]   MIGRAINE EPILEPSY RELATIONSHIPS [J].
ANDERMANN, F .
EPILEPSY RESEARCH, 1987, 1 (04) :213-226
[3]   DRUG-RELATED HEADACHE [J].
ASKMARK, H ;
LUNDBERG, PO ;
OLSSON, S .
HEADACHE, 1989, 29 (07) :441-444
[4]   A Bayesian neural network method for adverse drug reaction signal generation [J].
Bate, A ;
Lindquist, M ;
Edwards, IR ;
Olsson, S ;
Orre, R ;
Lansner, A ;
De Freitas, RM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) :315-321
[5]   Anxiety in patients with epilepsy: Systematic review and suggestions for clinical management [J].
Beyenburg, S ;
Mitchell, AJ ;
Schmidt, D ;
Elger, CE ;
Reuber, M .
EPILEPSY & BEHAVIOR, 2005, 7 (02) :161-171
[6]  
Bourne JA, 2001, CNS DRUG REV, V7, P399
[7]   SEIZURE PROMOTION AND PROTECTION BY D-1 AND D-2 DOPAMINERGIC DRUGS IN THE MOUSE [J].
BURKE, K ;
CHANDLER, CJ ;
STARR, BS ;
STARR, MS .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 36 (04) :729-733
[8]   Antidepressants and seizures: Clinical anecdotes overshadow neuroscience [J].
Dailey, JW ;
Naritoku, DK .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (09) :1323-1329
[9]   Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system [J].
Dani, John A. ;
Bertrand, Daniel .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 :699-729
[10]   HARMONIZATION IN PHARMACOVIGILANCE [J].
EDWARDS, IR ;
BIRIELL, C .
DRUG SAFETY, 1994, 10 (02) :93-102